In a recent interview at Machinecon USA 2023, Shameer Khader, a leader from the biopharmaceutical company Sanofi, delved into the transformative role of artificial intelligence (AI) in the realm of healthcare and pharmaceuticals. His insights provide a glimpse into the future of patient-centric treatments and the harmonious integration of AI in healthcare.
Chasing the Miracles of Science with AI
Sanofi, as Khader describes, is a company dedicated to "chasing the miracles of science." They harness the power of data, AI, machine intelligence, and the invaluable data from clinical trials and experiments. Khader leads the computational biology cluster within Sanofi, a part of the precision medicine function. The primary goal of precision medicine is to develop treatments tailored to indi
Tailoring Treatments with AI: Insights from Sanofi’s Shameer Khader
- By 理想
- Published on
Shameer Khader from Sanofi delves into the transformative role of AI in healthcare, emphasizing a future where tailored treatments and human-AI hybrid interactions coexist harmoniously.
